Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

National prevalence and trends of HIV transmitted drug resistance in Mexico.

PloS one - 1 Jan 2011

Avila-Ríos Santiago, García-Morales Claudia, Garrido-Rodríguez Daniela, Ormsby Christopher E, Hernández-Juan Ramón, Andrade-Villanueva Jaime, González-Hernández Luz A, Torres-Escobar Indiana, Navarro-Álvarez Samuel, Reyes-Terán Gustavo

Abstract excerpt

BACKGROUND: Transmitted drug resistance (TDR) remains an important concern for the management of HIV infection, especially in countries that have recently scaled-up antiretroviral treatment (ART) access. METHODOLOGY/PRINCIPAL FINDINGS: We designed a study to assess HIV diversity and transmitted drug resistance (TDR) prevalence and trends in Mexico. 1655 ART-naïve patients from 12 Mexican states were enrolled from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to DNA-Directed RNA Polymerases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Epidemics

Share to HIV Infections

Share to Mexico

Share to Prevalence

Source

Open in PubMed Open full text

Identifiers

PMID: 22110765
DOI: 10.1371/journal.pone.0027812
PMCID: PMC3217006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

National prevalence and trends of HIV transmitted drug resistance in Mexico.PMID 22110765Read ↗

HIV pretreatment drug resistance trends in three geographic areas of Mexico.Semantic proximity Read ↗

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.Semantic proximity Read ↗

Pretreatment HIV drug resistance spread within transmission clusters in Mexico City.Semantic proximity Read ↗

Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

Protease and Gag Diversity and Drug Resistance Mutations Among Treatment-Naive Mexican People Living with HIVSemantic proximity Read ↗

Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.Semantic proximity Read ↗

Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DCSemantic proximity Read ↗

Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.Semantic proximity Read ↗

Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.Semantic proximity Read ↗

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapySemantic proximity Read ↗

HIV-1 Diversity and Drug Resistance in Treatment-Naïve Children and Adolescents from Rio de Janeiro, Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.